Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$10.7M Sell
193,180
-3,827
-2% -$207K 2.12% 9
2025
Q4
$9.66M Sell
197,007
-33,110
-14% -$1.54M 2.05% 11
2025
Q3
$9.93M Buy
230,117
+5,258
+2% +$205K 2.27% 3
2025
Q2
$8.63M Sell
224,859
-960
-0.4% -$36.7K 2.02% 14
2025
Q1
$8.75M Buy
225,819
+9,819
+5% +$359K 2.13% 8
2024
Q4
$7.31M Buy
216,000
+17,578
+9% +$633K 1.96% 13
2024
Q3
$8.11M Buy
198,422
+229
+0.1% +$9.37K 2.03% 13
2024
Q2
$7.63M Buy
198,193
+3,231
+2% +$136K 2.01% 14
2024
Q1
$8.36M Buy
194,962
+13,439
+7% +$554K 2.11% 7
2023
Q4
$6.73M Buy
181,523
+26
+0% +$933 1.87% 14
2023
Q3
$6.58M Buy
181,497
+1,419
+0.8% +$50.4K 1.95% 14
2023
Q2
$6.42M Buy
180,078
+556
+0.3% +$19.9K 1.9% 16
2023
Q1
$6.39M Buy
179,522
+5,827
+3% +$204K 1.95% 19
2022
Q4
$6.1M Buy
173,695
+3,849
+2% +$128K 1.92% 13
2022
Q3
$5M Buy
169,846
+85,373
+101% +$3.24M 1.91% 5
2022
Q2
$4.6M Buy
+84,473
New +$4.66M 1.49% 18

Other funds holding GSK